Active Ingredient(s): Bedaquiline
FDA Approved: * December 28, 2012
Pharm Company: * JANSSEN R AND D
Category: Tuberculosis

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Sirturo Overview

Bedaquiline, sold under the brand name Sirturo, is a medication used to treat active tuberculosis.[1] Specifically, it is used to treat multi-drug-resistant tuberculosis (MDR-TB) along with other medications for tuberculosis.[1][5][6] It is used by mouth.[7] Common side effects include nausea, joint pains, headaches, and chest pain.[1] Serious side effects include QT prolongation, liver dysfunction...

Read more Sirturo Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Sirturo Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Tablet: 100mg, 20mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Sirturo: (2 results)

Sorted by National Drug Code
  • 59676-701 Sirturo 100 mg Oral Tablet by Janssen Products, Lp
  • 59676-702 Sirturo 20 mg Oral Tablet by Janssen Products, Lp

Other drugs which contain Bedaquiline or a similar ingredient: (1 result)